StockData
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) shareholders

GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.35−0.05 (-3.54%)

Close on Nov 17, 2026Market cap $2.95MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
4.3%
0M of 2M shares
Institutional holders
11
6 new, 1 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Mitchell P. Kopin
Joint filing with Daniel B. Asher (9.99%), Intracoastal Capital LLC (9.99%)
1,097,8589.99%13G (passive) amendmentDec 31, 2025
Intracoastal Capital, LLC
Joint filing with Mitchell P. Kopin (9.99%), Daniel B. Asher (9.99%)
677,4779.99%13G (passive)Dec 11, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of GRIValueChange% of portfolio
Hrt Financial LP28,7841.32%$50.00KNew0.00%
Vanguard Capital Management LLC21,3680.98%$37.82KNew0.00%
Geode Capital Management, LLC13,8690.63%$24.55K−4,5690.00%
Citadel Advisors LLC13,3760.61%$23.68KNew0.00%
Morgan Stanley8,7370.40%$15.46KNew0.00%
UBS Group AG4,9200.23%$8.71K−3,8020.00%
Tower Research Capital LLC (TRC)2,4340.11%$4.31K+1,3740.00%
Barclays PLC830.00%$147New0.00%
BlackRock, Inc.70.00%$12–0.00%
Danske Bank A/S20.00%$4–0.00%
Caitong International Asset Management Co., Ltd20.00%$4New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026110M4.3%6 / 12 / 10M0M
Q1 202660M1.3%5 / 00 / 00M0M
Q4 202510M0.0%1 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of GRIValue% of fundAs of
Vanguard Extended Market Index Fund21,3680.98%$37.82K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund13,7070.63%$28.92K0.00%May 31, 2026
Fidelity Series Total Market Index Fund8720.04%$1.84K0.00%May 31, 2026
Blackstone Alternative Multi-Strategy Fund-1-0.00%-$2-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Walter Marc HertzChief Executive Officer, Director385,51017.63%Sep 22, 2025
Leanne KellyChief Financial Officer6,2500.29%Sep 22, 2025
Vipin ChaturvediChief Scientific Officer172,1897.88%Sep 22, 2025
Roelof RongenDirector––Nov 13, 2026
David Charles BakerDirector7,8430.36%Nov 13, 2026
David Leslie SzekeresDirector––Nov 13, 2026
Camilla V. SimpsonDirector––Nov 13, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Vipin Chaturvedi
Chief Scientific Officer
Apr 21, 2023Award+172,189––172,189
Albert Agro
Chief Medical Officer
Apr 21, 2023Award+172,189––172,189
Walter Marc Hertz
Chief Executive Officer, Director, 10% owner
Apr 21, 2023Award+385,510––385,510
Marella Thorell
Director
Dec 13, 2022Other−28,517––9,506
Marella Thorell
Director
Jul 1, 2022Award+38,023––38,023
Leanne Kelly
Chief Financial Officer
Jun 4, 2021Buy+1,508$4.08$6.15K6,250
Leanne Kelly
Chief Financial Officer
Jun 3, 2021Buy+1,085$4.05$4.39K4,742
Leanne Kelly
Chief Financial Officer
Jun 2, 2021Buy+3,657$4.00$14.63K3,657
Joseph E. Payne
Director
May 26, 2021Buy+6,800$4.50$30.60K17,500
Joseph E. Payne
Director
May 25, 2021Buy+10,700$3.85$41.20K10,700
Richard Ammer
Director
Feb 12, 2021Other+47,063$6.40$301.20K47,063
David Charles Baker
Chief Executive Officer, Director
Feb 12, 2021Other+7,843$6.40$50.20K7,843
David Charles Baker
Chief Executive Officer, Director
Feb 12, 2021Buy+1,000$8.00$8.00K8,843
Pharma GmbH SALMON
10% owner
Feb 12, 2021Other+47,063$6.40$301.20K47,063

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
4.12%
0M shares short
Days to cover
1.6
At 0M shares a day
Change since last report
+0.6%
From 0M shares
Short volume, 20 days
33.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of GRI Bio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 26,534 shares on Sep 8, 2026 over the last 90 days.

See a number that looks wrong?